Related Experiment Video

Updated: Aug 5, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Epstein-Barr virus and multiple sclerosis: Mechanisms, therapeutic implications, and emerging interventions

Mohamed Reda Fazazi1, Kevin Champagne-Jorgensen2, Tamanna Islam3

  • 1Axe Neurosciences, Centre de recherche du CHU de Québec-Université Laval, 2705 blvd Laurier, Québec, QC G1V 4G2, Canada.

Journal of Neuroimmunology
|August 1, 2026
PubMed

Insights

Epstein-Barr virus (EBV) is strongly linked to multiple sclerosis (MS) onset and progression. New therapies targeting EBV offer promising treatment avenues for this neuroinflammatory disease.

Area of Science:

  • Neuroimmunology
  • Virology
  • Demyelinating Diseases

Background:

  • Multiple sclerosis (MS) is a chronic neuroinflammatory disease.
  • Genetic and environmental factors contribute to MS pathogenesis.
  • Epstein-Barr virus (EBV) is the leading environmental risk factor for MS.

Purpose of the Study:

  • To review the evidence linking EBV to MS.
  • To examine EBV's impact on current MS therapies.
  • To explore novel EBV-targeted therapeutic strategies for MS.

Main Methods:

  • Literature review of current scientific evidence.
  • Analysis of EBV's role in MS initiation, relapses, and progression.
  • Evaluation of existing MS treatments' effects on EBV.
  • Assessment of emerging EBV-specific therapies.

Main Results:

  • Strong evidence shows EBV infection precedes MS onset.
  • EBV may drive MS through molecular mimicry, B cell immortalization, and reactivation.
  • Current MS therapies may indirectly impact EBV by affecting lymphocytes.
  • Novel strategies like CAR-T/NK cells and vaccines aim to directly target EBV.

Conclusions:

  • EBV plays a significant role in the development and potentially the progression of MS.
  • Targeting EBV directly presents a promising therapeutic avenue for MS.
  • Further research into EBV-specific interventions is warranted for MS treatment.
Keywords:
AntiviralsCAR T cellsEpstein-Barr virus (EBV)Experimental autoimmune encephalomyelitis (EAE)Multiple sclerosis (MS)NK cellsNeutralizing antibodiesVaccine

More Related Videos

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...